{"disease":{"id":"chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp","name":"chronic inflammatory demyelinating polyradiculoneuropathy cidp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05363358","title":"A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06747351","title":"A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":59,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06798012","title":"A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03861481","title":"A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"UCB Biopharma S.P.R.L.","has_results":true},{"nct_id":"NCT06538064","title":"A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05084053","title":"A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03864185","title":"The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Nagoya University","has_results":false},{"nct_id":"NCT04051944","title":"A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}